## Session overview Defense and life-sciences names powered the top of the leaderboard as RTX and Danaher each rallied more than 7% on beat-and-raise quarters and standout sector performance. Mega-cap earnings told a different story, with Tesla, Alphabet,

Verdict: promising but wait for daily confirmation

The idea's strongest pillar is RTX's 60-month backtest — a 32.2% total return across 13 trades with a 61.5% win rate, anchored by top-1% free cash flow generation ($7.9 billion) and a reasonable 0.53 debt-to-equity ratio. The thesis argues defense and life-sciences momentum can persist on beat-and-raise catalysts, and per the cited Yahoo Finance coverage, RTX's 7% session rally on record Pentagon backlogs supports that narrative. But walk-forward testing found no robust parameter setup, and the basket's weaker constituents drag conviction: Oracle carries negative $23.7 billion in free cash flow (bottom percentile), Comcast shows essentially flat revenue growth at -0.02% year-over-year, and T-Mobile's 1.37 debt-to-equity is the highest leverage in the ten-stock universe. DHR's hourly RSI at 84.0 already sits in its exit zone, and the diversification ratio of 2.94 could compress sharply in a correlated sell-off. A waiting stance on the remaining basket names is warranted until daily crossovers complete. **Conviction breakdown** - **Thesis support (55):** RTX and DHR fundamentals partially validate the beat-and-raise narrative, but 2.9% revenue growth at DHR and broader mega-cap weakness temper enthusiasm. - **Trade readiness (60):** RTX's secondary entry is live in hourly data, but most basket names have not completed their crossover conditions on the daily timeframe. - **Risk quality (45):** The 18.6% max drawdown is meaningful, exit fills are approximate, and the optimizer's best candidate breached the risk guardrail. - **Backtest evidence (55):** A 32.2% return with a 61.5% win rate on RTX is credible, but the 24-month window softened to 9.8% returns and no robust setup was established. - **Fundamentals trend (50):** RTX, DHR, JNJ, and GOOGL show solid cash generation, but ORCL's cash burn, CMCSA's declining margins, and TSLA's 4.6% ROE offset the leadership names.

Trade now

The strategy trades a six-name defense and life-sciences basket (RTX, LMT, NOC, GD, LHX, DHR) on daily charts, requiring three conditions to align for a primary long entry: the 9-period EMA crossing above the 21-period EMA, a 14-period ADX reading above 25, and a 14-period RSI below 75. The idea's thesis centers on RTX and Danaher each rallying more than 7% on standout sector performance and beat-and-raise quarters. Per the live hourly data for RTX — the pair that drove the 60-month backtest returning 32.2% with a 61.5% win rate — the 9-period EMA at 217.6 sits comfortably above the 21-period EMA at 213.2, ADX is 82.6 (well past the 25 threshold), and RSI is 66.2 (below the 75 ceiling). The secondary crossover entry that omits the support-touch test is therefore live. DHR, the other featured gainer, has ADX at 37.7 and its EMA-9 at 194.0 is above EMA-21 at 191.8 — but RSI at 84.0 exceeds the 75 entry ceiling, so the crossover entry is blocked until momentum cools. "Wait" means watching for EMA crossovers to complete on the daily timeframe for names where the 9-period has not yet reclaimed the 21-period. GOOGL, TMUS, TSLA, and XOM all have their 9-period EMA below the 21-period EMA in the hourly data, meaning a bullish crossover has not yet fired. For the primary entry variant that also requires price to touch the nearest support level, RTX would need its daily low to reach or breach the rank-1 support before reclaiming it on close — the hourly data shows last close at 218.4, with the next nearest daily support and resistance levels defining the risk band. Risk is defined by a fixed stop at 2.7% downside from entry and a take-profit at 5.5% upside, producing an effective reward-to-risk ratio of roughly 2:1. Fibonacci-based exits add a structural layer: the 78.6% retracement acts as a secondary stop and the 127.2% extension serves as a secondary target. The 60-month backtest on RTX recorded a worst drawdown of 18.6%, and the most recent 24-month window returned 9.8% with a 13.1% drawdown and a 55.6% win rate across 9 trades. No robust parameter setup was established — the walk-forward optimizer's selected candidate increased holdout drawdown beyond the risk guardrail, so the frozen baseline configuration stands. Note that exits were filled on daily bars, not intraday precision data, so reported drawdown and win rates are coarse approximations. Position sizing caps each name at 16.7% of portfolio with a minimum trade value of $100.

Defense momentum meets fundamental tailwinds

The backtested evidence for this thesis is anchored by a solid historical track record on the RTX component. Over a 60-month evaluation window, the rule set produced a 32.2% total return across 13 trades with a 61.5% win…

Scores

• Conviction score breakdown: 53
• Thesis support: 55
• Trade readiness: 60
• Risk quality: 45
• Backtest evidence: 55
• Fundamentals trend: 50

Watch items

• RTX — EMA (9) vs EMA (21)
• RTX — ADX (14)
• RTX — RSI (14)
• DHR — RSI (14)
• XOM — EMA (9) vs EMA (21)
• MRK — EMA (9) vs EMA (21)
• CMCSA — EMA (9) crossed above EMA (21)
• CMCSA — ADX (14) above 25
• CMCSA — RSI (14) below 75